Propel Careers, MassBio, and the MassBioEd have joined together to organize a series of networking and panel events focused on raising awareness of career paths that exist in life sciences for individuals with advanced degrees. This Futures in Life Science program will bring together experts across a wide range of disciplines and functional areas within the life science industry, who will detail their roles and will provide a rich context for the audience to gain a clear understanding of the skills, aptitudes, competencies, and personalities that thrive in their particular functions.
On May 17th 2011, Propel Careers, MassBio, and MassBioEd will host our next Futures in Life Science Seminar Event Program. This event will focus on the Clinical Development, Regulatory, and Medical Affairs areas within the life sciences industry and will focus on the various career options within these areas. This panel discussion and networking event has an esteemed lineup of individuals who will share their perspectives.
Attendance for this program is open to current graduate students, post doctoral fellows, and medical residents who are interested in careers in the life sciences industry. Space is limited to 100 individuals. Below are more details for the event including registration details:
Date: May 17th, 2011
Location: MassBio Offices, One Cambridge Center, Cambridge, MA 02142
Time: 5:30pm – 8:00pm
To register: http://futuresinlifesciences4.eventbrite.com/
5:30pm-6:00pm – Registration and Open Networking 6:00pm-6:10pm – Introductions, Overview, and Recognition of Sponsors
6:10pm-7:30pm – Panel Discussion
Moderator: Laurie Halloran, President and CEO at Halloran Consulting Group
Panelists: Dana Martin, PharmD Senior Director, Medical Affairs, Genzyme; Kevin Pojasek, PhD VP, Corporate Development, Kala Pharma; Mike Poole, MD CMO, Link Medicine; Shawna Cullen, Ph.D., Clinical Trial Head, Oncology, Novartis; Patrick Melvin, Executive Director, Clinical Development, INC Research
7:30pm-8:00pm – Open Networking
Additional events are being planned for the areas below.
October: Commercialization 2 (Reimbursement/Market Access/Pharmacoeconomics)
November: Finance, Legal, Operations